Top

Letrozole Tablets IP 2.5 mg

Original price was: ₹80.00.Current price is: ₹50.00.

Specification Details
Product Name Letrozole Tablets IP 2.5 mg
Packaging Size 10X5
Packaging Type Strip with Box
Brand Name Torso Letrozole
Form Tablet
Strength 2.5 mg
Shelf Life 24 Months
Usage Treats hormone-receptor-positive breast cancer in postmenopausal women.
Route of Administration Oral
Storage Store below 30°C, protect from light and moisture
Certification WHO-GMP, ISO, DCGI
Supply & Export Available for the domestic and international markets
Manufacturer Name Torso Healthcare
Country of Origin Baddi, Himachal Pradesh (Made in India)
- +
Category: Tags: ,

Description

Letrozole tablets IP 2.5 mg are an aromatase inhibitor medication that is used to treat breast cancer by reducing the amount of estrogen (a natural female hormone) produced in the body. This reduction in estrogen can slow down or stop the growth of some breast cancers. Letrozole tablets IP 2.5 mg should be taken under your doctor’s or healthcare professional’s proper guidance. Take this medication orally with a glass of water.

Benefits

  • Fights Breast Cancer: Reduces estrogen to treat hormone-sensitive cancers.
  • Boosts Fertility: Stimulates ovulation to aid conception.
  • Generally Well-Tolerated: Often has fewer severe side effects than alternatives.

Side Effects

  • Hot Flushes
  • Difficulty Sleeping
  • Tiredness
  • Low Mood

Letrozole Tablets IP 2.5 mg Manufacturers in India

Letrozole Tablets IP 2.5 mg are an aromatase inhibitor medication that is used to treat breast cancer. This medication reduces the amount of estrogen (a natural female hormone) produced in the body. Torso Healthcare is the leading manufacturer of Letrozole tablets IP 2.5 mg in India.

The company is an ISO, WHO, and GMP-certified pharmaceutical manufacturer in India. We consistently deliver high-quality, reliable medicines by strictly adhering to standardized industry practices. Since we have a strong reputation in the pharmaceutical industry, we always provide solutions to our clients.

THIRD-PARTY ENQUIRY FORM


    At vero eos et accusamus et iusto odio dignissimos qui blanditiis praesentium voluptatum.